NCT02319681

Brief Summary

This study seeks to establish the acceptability and evaluate the limited efficacy of Simple Reminiscence (SR), a home-delivered non-pharmacological intervention designed to relieve stress, improve affect, and prevent or quell disruptive or maladaptive behaviors in community-residing individuals diagnosed with early Alzheimer's disease (EAD). Unmanaged episodes of anxiety can be antecedents of maladaptive behaviors, including agitation, anger, and sometimes even violence. SR is a dyadic strategy; both the person with EAD and the caregiver engaged the patient's memory to interrupt a current episode of anxiety.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 18, 2014

Completed
14 days until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

June 26, 2015

Status Verified

June 1, 2015

Enrollment Period

1.9 years

First QC Date

December 15, 2014

Last Update Submit

June 25, 2015

Conditions

Keywords

CaregiversAnxietyDepression

Outcome Measures

Primary Outcomes (1)

  • Acceptability of SR and AC

    Taped interview with the dyad will occur asking how acceptable the format, duration, and frequency of the program

    Week 20

Secondary Outcomes (10)

  • Number of times AC was used

    Week 20

  • Number of times SR was used

    Week 20

  • Change in Beck Depression Inventory-II (BDI-II) scale

    Baseline, week 20

  • Change in State-Trait Anxiety Inventory (STAI) scale

    Baseline, week 20

  • Change in Katz Instrumental Activities of Daily Living (IADL) scale

    Baseline, week 20

  • +5 more secondary outcomes

Study Arms (2)

Simple Reminiscence (SR) caregiver

EXPERIMENTAL

Subjects are caregivers for a persons with EAD and will be administered SR intervention and an attention control treatment four times

Behavioral: Simple Reminiscence (SR)Behavioral: Attention Control (AC)

Simple Reminiscence (SR) EAD

EXPERIMENTAL

Subjects are persons with EAD and will be administered SR intervention and an attention control treatment four times

Behavioral: Simple Reminiscence (SR)Behavioral: Attention Control (AC)

Interventions

SR is a 30-minute psychoeducational activity administered by a trained RA at 4 home visits (week 2, week 3, week 7, and week 19). SR has a didactic component using the SR manual that the couple retains, viewing one of the brief video-vignettes illustrating the application of reminiscence techniques (a different video-vignette will be viewed at each visit), and facilitation of caregiver practice in applying the techniques, using a recent example of anxiety-linked experience of the person with EAD.

Simple Reminiscence (SR) EADSimple Reminiscence (SR) caregiver

AC is a 30-minute in which the person with EAD, the caregiver and the RA review and discuss the day's newspaper headlines. The RA will use communication techniques specifically designed to keep the conversation present focused at 4 home visits (week 2, week 3, week 7, and week 19).

Simple Reminiscence (SR) EADSimple Reminiscence (SR) caregiver

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Live in the community
  • Reside with a primary caregiver who must be willing to participate in all study activities (the primary caregiver must have a familial or marital relationship with the person with EAD of sufficient length to support reminiscence activity \[i.e., an adult child, a long-term spouse or committed partner\])
  • Have received a diagnosis of Early Alzheimer's Disease from a primary care provider
  • Achieve a score on the mini-mental state examination (MMSE) between 19 and 25

You may not qualify if:

  • Unable to give consent
  • MMSE score lower than 19 or greater than 25.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Alzheimer's Disease Research Center

Atlanta, Georgia, 30329, United States

Location

MeSH Terms

Conditions

Alzheimer DiseaseAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • William Puentes, PhD RN FAAN

    Emory University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 15, 2014

First Posted

December 18, 2014

Study Start

January 1, 2015

Primary Completion

December 1, 2016

Study Completion

June 1, 2017

Last Updated

June 26, 2015

Record last verified: 2015-06

Locations